Table 2 Summary of background information of patients with other lung diseases and healthy volunteers used for LPC biomarker assay.

From: Identification and characterization of lysophosphatidylcholine 14:0 as a biomarker for drug-induced lung disease

Factor

Category

Lung cancer

Bacterial pneumonia

Nontuberculous mycobacteriosis

Idiopathic interstitial pneumonia

Lung disease associated with connective tissue disease

Chronic obstructive pulmonary disease

Bronchial asthma

Healthy volunteer

no. of subjects

 

68

10

20

39

23

13

12

90

Age

Range/median (no. of sub.)

44–81/70.5 (68)

55–81/73.5 (10)

48–83/64.5 (20)

41–83/72.5 (38)

50–83/68 (23)

51–80/66 (13)

42–87/60 (12)

25–65/47 (90)

Gender

Female/male (no. of sub.)

20/48 (68)

3/7 (10)

15/5 (20)

8/31 (39)

16/7 (23)

2/11 (13)

8/4 (12)

45/45 (90)

BMI

Range/median (no. of sub.)

15.9–30.4/21.9 (67)

16.5–29.3/22.8 (10)

12.7–24.7/18.7 (20)

15.7–32.4/24.3 (39)

19.9–44.3/23.7 (23)

13–29.4/21.1 (13)

18.7–32/24.5 (12)

18.4–25.6/21.4 (90)

Smoking habit

No/Yes (no. of sub.)

14/52 (66)

4/6 (10)

15/4 (19)

5/34 (39)

12/10 (22)

0/13 (13)

6/5 (11)

NA

Chest radiation

No/Yes (no. of sub.)

60/8 (68)

9/1 (10)

19/1 (20)

38/0 (38)

23/0 (23)

12/0(12)

12/0 (12)

NA